77 related articles for article (PubMed ID: 12200819)
1. Anti-glomerular basement membrane nephritis and bullous pemphigoid caused by distinct anti-alpha 3(IV)NC1 and anti-BP180 antibodies in a patient with Crohn's disease.
Plaisier E; Borradori L; Hellmark T; Wattiaux MJ; Flageul B; Mougenot B; Ronco P
Am J Kidney Dis; 2002 Sep; 40(3):649-54. PubMed ID: 12200819
[TBL] [Abstract][Full Text] [Related]
2. The Prevalence and Characteristics of Circulating IgA Anti-Glomerular Basement Membrane Autoantibodies in Anti-Glomerular Basement Membrane Disease.
Yang XF; Kuang H; Shen CR; Cui Z; Yu XJ; Ma YY; Zhao MH; Jia XY
Kidney Int Rep; 2023 Nov; 8(11):2395-2402. PubMed ID: 38025241
[TBL] [Abstract][Full Text] [Related]
3. Identification of a nephritogenic immunodominant B and T cell epitope in experimental autoimmune glomerulonephritis.
Reynolds J; Haxby J; Juggapah JK; Evans DJ; Pusey CD
Clin Exp Immunol; 2009 Feb; 155(2):311-9. PubMed ID: 19040602
[TBL] [Abstract][Full Text] [Related]
4. Bullous pemphigoid induced by IgG targeting type XVII collagen non-NC16A/NC15A extracellular domains is driven by Fc gamma receptor- and complement-mediated effector mechanisms and is ameliorated by neonatal Fc receptor blockade.
Pigors M; Patzelt S; Reichhelm N; Dworschak J; Khil'chenko S; Emtenani S; Bieber K; Hofrichter M; Kamaguchi M; Goletz S; Köhl G; Köhl J; Komorowski L; Probst C; Vanderheyden K; Balbino B; Ludwig RJ; Verheesen P; Schmidt E
J Pathol; 2024 Feb; 262(2):161-174. PubMed ID: 37929639
[TBL] [Abstract][Full Text] [Related]
5. Uncommon structural motifs dominate the antigen binding site in human autoantibodies reactive with basement membrane collagen.
Foster MH; Buckley ES; Chen BJ; Hwang KK; Clark AG
Mol Immunol; 2016 Aug; 76():123-33. PubMed ID: 27450516
[TBL] [Abstract][Full Text] [Related]
6. Autoantibodies against laminin-521 are pathogenic in anti-glomerular basement membrane disease.
Kuang H; Shen CR; Jia XY; Tan M; Yang XF; Cui Z; Borza DB; Zhao MH
Kidney Int; 2023 Dec; 104(6):1124-1134. PubMed ID: 37598856
[TBL] [Abstract][Full Text] [Related]
7. Gelatinase B-deficient mice are resistant to experimental bullous pemphigoid.
Liu Z; Shipley JM; Vu TH; Zhou X; Diaz LA; Werb Z; Senior RM
J Exp Med; 1998 Aug; 188(3):475-82. PubMed ID: 9687525
[TBL] [Abstract][Full Text] [Related]
8. Anti-α6β4 integrin autoantibodies inhibit the binding of laminins to α6β4 integrin in patients with pemphigoid and affect the gastrointestinal tract.
Arase N; Sasaoka Y; Narita J; Kiyohara E; Hashimoto K; Shinzaki S; Nojima S; Takagi J; Fujimoto M
J Eur Acad Dermatol Venereol; 2024 Feb; 38(2):404-412. PubMed ID: 37857595
[TBL] [Abstract][Full Text] [Related]
9. Mucosal tolerance induced by an immunodominant peptide from rat alpha3(IV)NC1 in established experimental autoimmune glomerulonephritis.
Reynolds J; Abbott DS; Karegli J; Evans DJ; Pusey CD
Am J Pathol; 2009 Jun; 174(6):2202-10. PubMed ID: 19406992
[TBL] [Abstract][Full Text] [Related]
10. Detection of a natural antibody targeting the shed ectodomain of BP180 in mice.
Mai Y; Izumi K; Mai S; Nishie W; Ujiie H
J Dermatol Sci; 2023 Oct; 112(1):15-22. PubMed ID: 37550175
[TBL] [Abstract][Full Text] [Related]
11. Bullous Pemphigoid in X-linked Alport Syndrome.
Yamawaki M; Katayama K; Fujimoto M; Goto H; Yuasa H; Kozuka Y; Mori M; Takahashi D; Saiki R; Hirabayashi Y; Murata T; Yamanaka K; Dohi K
Intern Med; 2023 Aug; 62(16):2375-2379. PubMed ID: 36543213
[TBL] [Abstract][Full Text] [Related]
12. Laminin-521: a novel target for pathogenic autoantibodies in anti-glomerular basement membrane disease.
Robson KJ
Kidney Int; 2023 Dec; 104(6):1054-1056. PubMed ID: 37981425
[TBL] [Abstract][Full Text] [Related]
13. Recovery of a human natural antibody against the noncollagenous-1 domain of type IV collagen using humanized models.
Worni-Schudel IM; Clark AG; Chien T; Hwang KK; Chen BJ; Foster MH
J Transl Med; 2015 Jun; 13():185. PubMed ID: 26048777
[TBL] [Abstract][Full Text] [Related]
14. Anti-glomerular basement membrane disease in children: a brief overview.
Dowsett T; Oni L
Pediatr Nephrol; 2022 Aug; 37(8):1713-1719. PubMed ID: 34767075
[TBL] [Abstract][Full Text] [Related]
15. Autoimmunity against laminin 332.
Patzelt S; Schmidt E
Front Immunol; 2023; 14():1250115. PubMed ID: 37638011
[TBL] [Abstract][Full Text] [Related]
16. Clinical and immunological characteristics of patients with combined anti-glomerular basement membrane disease and IgA nephropathy.
Shen CR; Jia XY; Cui Z; Yu XJ; Zhao MH
Clin Kidney J; 2023 Sep; 16(9):1480-1488. PubMed ID: 37664576
[TBL] [Abstract][Full Text] [Related]
17. Demonstration of equivocal anti-glomerular basement membrane antibody positivity as a non-specific reaction through multiple immunologic assays in a case of pediatric asymptomatic hematuria.
Sato M; Nishibata Y; Masuda S; Nagamori T; Ishibazawa E; Yoshida Y; Takahashi H; Ishizu A; Takahashi S
Clin Biochem; 2023 Oct; 120():110650. PubMed ID: 37734646
[TBL] [Abstract][Full Text] [Related]
18. Short-chain fatty acids ameliorate experimental anti-glomerular basement membrane disease.
Liu J; Gu QH; Cui Z; Zhao MH; Jia XY
Clin Immunol; 2024 Feb; 259():109903. PubMed ID: 38218211
[TBL] [Abstract][Full Text] [Related]
19. FcRn inhibition reduces bullous pemphigoid anti-basement membrane zone IgG deposition and blistering in 3D human skin equivalents.
Bao L; Perez White BE; Chang RC; Li J; Vanderheyden K; Verheesen P; Sips M; Brinkhaus M; Amber KT
J Invest Dermatol; 2024 Jun; ():. PubMed ID: 38885876
[No Abstract] [Full Text] [Related]
20. The Immunobiological Agents for Treatment of Antiglomerular Basement Membrane Disease.
Yamashita M; Takayasu M; Maruyama H; Hirayama K
Medicina (Kaunas); 2023 Nov; 59(11):. PubMed ID: 38004064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
